Product Information
MECLIZINE 50 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $2.4842 per EA under NDC 16571066201. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Meclizine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571066201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA010721FDA Approved
Before 1982
TE Code
AA
On Market Since
1/15/2020
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 50 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4842 per EA |
|---|---|
| All-time high | $2.5546 (Jan 14, 2026) |
| All-time low | $2.1724 (Feb 19, 2025) |
| 52-week high | $2.5546 |
| 52-week low | $2.4442 |
| Median price | $2.4548 |
| Average price | $2.4243 |
| Largest weekly change | -6.1% (Nov 20, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Meclizine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Meclizine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiemetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MECLIZINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 50 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $2.4842 per EA (NDC 16571066201), effective Sep 30, 2026.
How has the price of MECLIZINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 50 MG TABLET has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MECLIZINE 50 MG TABLET?
Since Apr 17, 2024, the NADAC for MECLIZINE 50 MG TABLET has ranged from a low of $2.1724 (Feb 19, 2025) to a high of $2.5546 (Jan 14, 2026), with a median of $2.4548 per EA.
Are there cheaper alternatives to MECLIZINE 50 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MECLIZINE 50 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MECLIZINE 50 MG TABLET?
MECLIZINE 50 MG TABLET (NDC 16571066201) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.